Document:

Exhibit 10.6 

 

CONFIDENTIAL

 

October 8, 2018

 

Brian McKelligon

[***]

[***]

[***]

 

Letter Amendment to “Brian McKelligon Offer
Letter - 20170705”

 

Dear Brian,

 

I am very pleased inform you of the following addendum to your
compensation as outlined in your signed offer dated July 5, 2017, Brian McKelligon Offer Letter - 20170705 (“Agreement”)

 

		8.	Annual Salary and Objective-Based Bonus: Effective September 28, 2018, you will be paid an annual salary of $300,000 in
semi-monthly installments. Payments will be subject to deductions for taxes and other withholdings as required by law or the policies
of the Company. In addition, you will have an opportunity to earn an annual bonus of up to 30% of your annual salary based upon
milestones to be mutually agreed upon between you and the Board of Directors. Your prior and new bonus amounts will be calculated
on a pro-rated basis with the increase for this revised bonus amount effective on September 28, 2018.

 

		9.	Equity: Subject to Board approval, you will be provided an option to acquire 578,581 shares, under the Company’s stock
option plan, subject to standard four-year vesting requirements (with a one-year cliff). You will also be granted an option to
acquire 192,860 shares subject to vesting based on achievement of certain milestones to be mutually agreed upon by you and the
Board of Directors. The total shares provided through this new option grant plus the shares from your existing option grant shall
equal 3% of the Company’s fully diluted shares following the closing of the Company’s Series C financing.

 

    www.akoyabio.com

     

    

 

 

The Board thank you for your continued dedication and hard

 

Sincerely,

 

	/s/ Robert Shepler	 
	Robert Shepler	 
	Board Director	 
	Akoya Biosciences, Inc.	 

 

I acknowledge and accept the compensation changes outline

 

	/s/ Brian McKelligan	 
	Brian McKelligan	 
	CEO	 
	Akoya Biosciences, Inc.	 
	 	 
	 	 
	October 8, 2018	 
	Date 	 

 

    www.akoyabio.comExhibit 10.7

 

 

January 28, 2019

 

Joseph S. Driscoll, CPA

[***]

[***]

 

Re. Employment by Akoya Biosciences, Inc.

 

Dear Joe,

 

I am pleased to provide you with this offer
to join Akoya Biosciences, Inc. (“Akoya” or the “Company”) in the position of Chief Financial Officer.
We are excited to have you as a critical member of the executive learn reporting to Chief Executive Officer, Brian McKelligon.
This offer and your start date are contingent on the full execution of this letter agreement. This offer expires at the end of
business on January 30, 2019. We anticipate your start date to be on or before March 15, 2019. Following the execution
of this offer letter, Akoya will enter into a separate consulting agreement with you to bridge the gap until your start date.

 

Compensation

 

You will be paid an annual a salary of
$300,000, payable in semi-monthly installments, subject to applicable tax withholding requirements. In addition, you will have
the opportunity to earn an annual cash bonus of up to $100,000 based a combination of your personal and the Company's annual goal
achievement. Personal and Company goals will be determined and approved by the CEO and Board of Directors. The payment of any bonus
shall be subject to your continued employment by the Company through the date of payment.

 

Equity Incentive

 

The Company will offer you participation
in our equity incentive program. Subject to Board approval, you will be provided an option to acquire the number of shares equivalent
to 1.35% on a fully diluted basis of Akoya's common stock under the Company's stock option plan (the “initial Option”).
You will vest 25% of the shares of the Initial Option after one year of employment with the remaining shares vesting in equal monthly
installments over the subsequent 38 months. Additionally, subject to Board approval, you will also be granted an option to acquire
an additional 0.5% of the Company's shares, (the “Performance Option” and together with the Initial Option, the “Options”).
The Performance Option will fury vest upon the achievement of certain milestones to be determined by the CEO and Board of Directors.
The vesting of the Options is subject to your continued employment with the company. In the event of both a Change of Control,
as defined in Akoya's 2015 Equity Incentive Plan (provided separately), and the termination of your employment, all outstanding,
unvested Options granted to you shall fully vest.

 

Akoya
Biosciences, Inc | 1505 O`Brien Drive, Suite A1 | Menlo Park, CA 94025 | 

www.akoyabio.com Confidential Information

 

    

    

    

 

Employee Benefits

 

In addition to the standard company holidays,
Akoya will provide you paid vacation, sick days and the option to enroll in the Company's health and other benefit plans. Please
refer to the attached benefits guide for details. Akoya Biosciences, Inc. will reimburse you for business travel and other
approved business expenses.

 

Employment Relationship

 

Your employment with Akoya is at-will and
either you or the Company can terminate your employment at any time with or without cause and with or without notice. Your acceptance
of this offer and commencement of employment with the Company are contingent upon the signing of this letter and your execution
of the Company's Confidential Information and Invention Assignment Agreement. In addition, in the event the Company terminates
your employment without cause, the Company will provide a lump sum payment equal to six months of your base salary at the date
of termination.

 

Your position, job description, salary,
and responsibilities may be modified from time to time at the sole discretion of the CEO and Board of Directors. You agree to devote
your full business time, attention and best efforts to Akoya during the term of your employment. We understand that you may need
to spend limited time assisting with the transition of your current pubic company responsibilities for approximately 30 days after
March 15 but all this time will be spent during off hours and it is anticipated not to exceed 5 hours per week. You further
agree to adhere to the Company policies as set forth in the Employee Handbook.

 

All forms of compensation referred to in
this letter are subject to withholdings and any other deductions required by applicable law.

 

Counterparts

 

This letter may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
Execution of a facsimile or scanned image will have the same force and effect as execution of an original, and a facsimile signature
or scanned image will be deemed an original and valid signature.

 

If you wish to accept this offer, please
sign and date this letter and the enclosed Confidential Information and Invention Assignment Agreement and return them to me. As
required by law, your employment with the Company is also contingent upon your providing legal proof of your Identity and authorization
to work in the United States.

 

We look forward to you joining the Akoya
team and believe that together we can build a transformative company. We are delighted to offer you this opportunity and are excited
that you are joining our leadership team.

 

Sincerely,

 

Brian McKelligon

Chief Executive Officer

 

Akoya
Biosciences, Inc | 1505 O`Brien Drive, Suite A1 | Menlo Park, CA 94025 | 

www.akoyabio.com Confidential Information

 

    

    

    

 

I have read and understand the provisions
of this offer letter, and I accept the offer of employment.

 

	/s/ Joe Driscoll	 
	Joe Driscoll
	 
	January 28, 2019	 
	Date

 

Attachments:         Benefits Summary 

Confidential Information and invention Assignment Agreement

 

Akoya
Biosciences, Inc | 1505 O`Brien Drive, Suite A1 | Menlo Park, CA 94025 |

 www.akoyabio.com Confidential InformationExhibit 10.8

 

 

 

July 14, 2020

 

Niroshan Ramachandran, Ph.D.

[***]

[***]

 

Re: Employment by Akoya Biosciences, Inc.

 

Dear Niro:

 

We are very excited about the prospects
of your joining Akoya Biosciences, Inc. Should you accept this offer and upon successful completion of a background check and drug
screen we look forward to having you joining the company as a regular, full-time employee. This letter will confirm the terms of
your employment.

 

Position and Duties:

 

You shall serve in the position of Chief
Strategy & Marketing Officer with Akoya Biosciences, Inc. reporting to Brian McKelligon, Chief Executive Officer.

 

Your position, job description, manager,
salary, duties and responsibilities may be modified from time to time in the sole discretion of Akoya Biosciences, Inc. You agree
to strictly adhere to all of the rules and regulations of Akoya Biosciences, Inc. as may be set forth in any Employee Handbook
or published policies of Akoya Biosciences, Inc. now or in the future, including all amendments to the Handbook which may be made
in the future in Akoya Biosciences, Inc.’s sole discretion (as published or amended from time to time, the “Manual”).

 

Compensation:

 

		(a)	Salary. Akoya Biosciences, Inc. shall pay you, and you agree to accept from Akoya Biosciences,
Inc. in payment for your services to Akoya Biosciences, Inc., a salary of $300,000.00 per year (the “Yearly Salary”),
payable in 24 equal installments of $12,500.00 on regular semi-monthly dates established by Akoya Biosciences, Inc., subject
to applicable tax withholding requirements. Any proposed increase of your salary, compensation or benefits must be approved by
Akoya’s CEO, Brian McKelligon.

 

		(b)	Annual Bonus. The Company has created an incentive pay plan under which you may be eligible
for an annual cash incentive bonus (the “Bonus”). Your annual target bonus opportunity (the “Bonus”)
will be 30% of your annual base salary. The actual Bonus payment received for fiscal year 2020 will be prorated based upon
your start date with the Company and at the sole discretion of the Company. Any bonus will be based on a combination of your personal
achievement as well as the Company’s ability to meet its financial performance objectives. The payment of any Bonus shall
be subject to your continued employment through the date of payment by the Company.

 

		(c)	Incentive Stock Options. The Company will offer you participation in an Equity Incentive
Program. Subject to approval by the Board of Directors of the Company (the “Board”), you will be provided an option
to acquire the number of shares equivalent to 400,000 shares of the Company’s common stock under the Company’s
stock option plan (the “Option”). You will vest as to 25% of the shares subject to the Option on the first anniversary
of your date of employment, with the remaining 75% of the shares subject to the Option vesting in equal monthly installments over
the subsequent 36 months on the same day of the month as your date of employment, subject to your continued service to the Company
through each applicable vesting date. The exercise price per share of the Option will be equal to the fair market value per share
of the Company’s common stock on the date the Option is granted, as determined by the Board in good faith. There is no guarantee
that the Internal Revenue Service will agree with this value. You should consult with your own tax advisor concerning the tax consequences
associated with accepting the Option.

 

1080 O’Brien Drive. Suite A1, Menlo Park, CA 94025 | 855.896.8401 | www.akoyabio.com |100 Campus Drive, 6th Floor, Marlborough,
MA 01752

 

     

     

    

 

 

 

No Other Employment:

 

You agree to devote your full business
time, attention and best efforts to the business of Akoya Biosciences, Inc. during the employment relationship. Akoya Biosciences,
Inc.’s normal business hours are from 8:30 a.m. to 5:30 p.m., Monday through Friday. As an exempt salaried employee,
however, you may be required to work additional hours depending on the nature of your work assignments.

 

Time Off:

 

Employees at this compensation band are
afforded unlimited PTO under the Akoya PTO policy as stated in the Employee Handbook.

 

Company Holidays:

 

The Company offers 9 paid Holidays per
calendar year. The company holidays are listed in the benefits guide.

 

Business Travel:

 

Company will reimburse reasonable travel
and lodging related expenses associated with business travel.

 

Benefit Plans:

 

You shall be entitled to participate in
any standard health and other benefit plans established by Akoya Biosciences, Inc. on terms as may be established by Akoya Biosciences,
Inc. in its sole discretion. Although you may be eligible for such benefits if they become available in the future, Akoya Biosciences,
Inc. does not promise or represent that such benefits will in fact become available or that once made available they will be continued.

 

Employee Expenses:

 

Akoya Biosciences, Inc. will reimburse
you for pre-approved business expenses (approved by the Chief Executive Officer, President, or the Board of Directors), as provided
within the guidelines of Akoya Biosciences, Inc.’s expense policy. All expenses shall be subject to review and approval by
your direct report and the CFO and shall require reasonable documentation.

 

Confidential Information and Invention
Assignment Agreement:

 

As a condition of your employment with
Akoya Biosciences, Inc., you acknowledge that you have executed and delivered a copy of Akoya Biosciences, Inc.’s Proprietary
Information and Inventions Agreement and will abide by its terms. You acknowledge that a remedy at law for any breach or threatened
breach by you of the provisions of the Proprietary Information and Inventions Agreement would be inadequate, and you therefore
agree that Akoya Biosciences, Inc. shall be entitled to injunctive relief in case of any such breach or threatened breach.

 

At-Will Employment:

 

Employment with Akoya Biosciences, Inc.
is employment at-will. Employment at-will may be terminated with or without cause and with or without notice at any time at the
will of either you or Akoya Biosciences, Inc. Terms and conditions of employment with Akoya Biosciences, Inc. may be modified at
the sole discretion of Akoya Biosciences, Inc. with or without cause and with or without notice. Other than the Chief Executive
Officer (“CEO”), no one has the authority to make any agreement for employment other than for employment at-will or
to make any agreement limiting Akoya Biosciences, Inc.’s discretion to modify the terms and conditions of employment. Only
the CEO has the authority to make any such agreement and then only in writing and signed by each of the CEO and the respective
employee. No implied contract concerning any employment-related decision or term, or condition of employment can be established
by any other statement, conduct, policy, or practice.

 

Governing Law:

 

This Agreement is made and shall be
construed and enforced in accordance with the laws of the State of California. This Agreement and the Exhibits supersede and
replace all prior agreements or understandings, oral or written, between Akoya Biosciences, Inc. and you, except for prior
confidentiality agreements, if any. This Agreement may not be modified except by a writing signed both by the CEO and by
you.

 

1080 O’Brien Drive. Suite A1, Menlo Park, CA 94025 | 855.896.8401 | www.akoyabio.com |100 Campus Drive, 6th Floor, Marlborough,
MA 01752

 

     

     

    

 

 

 

Arbitration:

 

In the event of any dispute in connection
with this Agreement or the Exhibits the parties agree to resolve the dispute by binding arbitration in San Francisco, California,
under the Commercial Arbitration Rules of the American Arbitration Association (“AAA”), with a single arbitrator familiar
with employment and technology agreements appointed by AAA. In the event of any dispute the prevailing party shall be entitled
to its reasonable attorneys’ fees and costs from the other party, whether or not the matter is litigated or arbitrated to
a final judgment or award. The arbitrator’s decision shall be final and binding on all parties and may be entered in any
court having competent jurisdiction.

 

Severability:

 

If any provision of this Agreement or the
Exhibits is determined to be invalid or unenforceable, the remainder shall be unaffected and shall be enforceable against both
Akoya Biosciences, Inc. and you.

 

This offer is contingent upon a background
check clearance, reference check, drug test and satisfactory proof of the employee’s night to work in the US, as required
by law.

 

Employee Review and Receipt of Agreement:

 

You acknowledge that you have carefully
read and considered all provisions of this Agreement and the Exhibits and agree that all of the restrictions set forth herein are
fair and reasonably required to protect Akoya Biosciences, Inc.’s interests. You acknowledge that you have received a copy
of this Agreement and the Exhibits as signed by you. You acknowledge that, prior to signing this Agreement, you have had an opportunity
to seek the advice of independent counsel of your choice relating to the terms of this Agreement.

 

	 	Sincerely
	 	 
	 	Akoya
    Biosciences, Inc
	 	 
	 	By	/s/ Brian
    McKelligon
	 	 
	 	Its 	Chief Executive Officer            
	 	 
	 	Date  	July 14, 2020

 

	Agreed to and Accepted
	 
	 
	/s/ Niroshan Ramachandran 	 	June 22, 2020
	[Employee Signature]	 	[Date]

 

1080 O’Brien Drive. Suite A1, Menlo Park, CA 94025 | 855.896.8401 | www.akoyabio.com |100 Campus Drive, 6th Floor, Marlborough,
MA 01752

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]